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Abstract
The tumor microcirculation is characterized by an abnormal vascular network with dilated, tortuous and saccular vessels.
Therefore, imaging the tumor vasculature and determining its morphometric characteristics represent a critical goal for
optimizing the cancer treatment that targets the blood vessels (i.e. antiangiogenesis therapy). The aim of this study was to
evaluate new vascular morphometric parameters in colorectal cancer, difficult to achieve through conventional
immunohistochemistry, by using the confocal laser endomicroscopy method. Fresh biopsies from tumor and normal
tissue were collected during colonoscopy from five patients with T3 colorectal carcinoma without metastasis and were
marked with fluorescently labeled anti-CD31 antibodies. A series of optical slices spanning 250 mm inside the tissue were
immediately collected for each sample using a confocal laser endomicroscope. All measurements were expressed as the
mean 6 standard error. The mean diameter of tumor vessels was significantly larger than the normal vessels (9.4660.4 mm
vs. 7.6060.3 mm, p=0.0166). The vessel density was also significantly higher in the cancer vs. normal tissue samples
(5541.056262.81 vs. 3755.796194.96 vessels/mm
3, p=0.0006). These results were confirmed by immunohistochemistry. In
addition, the tortuosity index and vessel lengths were not significantly different (1.0560.016 and 28.3063.27 mm in normal
tissue, vs. 1.0760.008 and 26.4963.18 mm in tumor tissue respectively, p=0.5357 and p=0.7033). The daughter/mother
ratio (ratio of the sum of the squares of daughter vessel radii over the square of the mother vessel radius) was 1.1560.09 in
normal tissue, and 1.2160.08 in tumor tissue (p=0.6531). The confocal laser endomicroscopy is feasible for measuring more
vascular parameters from fresh tumor biopsies than conventional immunohistochemistry alone. Provided new contrast
agents will be clinically available, future in vivo use of CLE could lead to identification of novel biomarkers based on the
morphometric characteristics of tumor vasculature.
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Introduction
The imbalance of pro- and anti-angiogenic signaling within
tumors creates an abnormal vascular network that is characterized
by dilated, tortuous, and hyperpermeable vessels [1], [2].
Therefore the tumor vascularization and in particular the growth
of new vessels (angiogenesis) has attracted increased attention in
the last two decades for possible applications to diagnosis,
prognosis stratification and targeted treatment [1].
Among methods to assess tumor vascularization, the determi-
nation of microvessel density (MVD) from immunohistochemistry
(IHC) samples is commonly used in preclinical and clinical studies.
MVD represents the average number of vessels per mm
2 within a
tissue sample but that measure alone is insufficient for monitoring
vascular changes over a treatment period [3]. Other functional
and morphologic parameters such as blood volume, permeability,
microvessel density, vessel diameter, branching patterns, other
measures of vessel shape and tumor metabolism can be associated
with tumor angiogenesis.
The mechanisms underlying the enhanced antitumor effects of
the combined treatments may differ among the antiangiogenic
agents, and have not been determined conclusively. Antiangio-
genic agents that disrupt the vascular endothelial growth factor
pathway have been demonstrated to normalize tumor vasculature.
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t ¸Some authors consider that the normalized vascular networks are
characterized by lower vessel tortuosity and lower vessel density.
[4], [5], [6].
The clinical monitoring of the effects of antiangiogenic therapy
requires an imaging modality that detects the morphological
characteristics of tumor vessels with high sensitivity and specificity.
Furthermore, since the antiangiogenic therapy requires repeated
treatments, a non-invasive technique is highly desirable [7].
Conventional imaging modalities such as computed tomography,
magnetic resonance or ultrasound do not give a detailed image of
the tumor vessels, resulting in limited use for in vivo cancer
evaluation [7]. Non-invasive characterisation of tumour vessels
leads to a better understanding of therapy effects and helps to
optimise and personalise therapeutic interventions. [8].
Confocal laser endomicroscopy (CLE) allows in vivo microscopic
analysis of the gastrointestinal mucosa and its microvascularization
during endoscopy by using topically or systemically administered
contrast agents [7], [9]. Targeting markers of angiogenesis, in
association with molecular CLE examinations (immunoendo-
scopy), adds functional analysis to the morphological aspect of the
neoplastic process [7]. Thus, in contrast to the conventional
methods of vascular assessment, CLE offers a unique opportunity
to selectively enhance different levels of the microvasculature.
In a previous study, we showed that the CLE method is feasible
for imaging different aspects of the tumor vasculature from fresh
biopsy samples similar to the currently accepted histopathology
techniques [9]. In this study, we evaluated new vascular network
parameters difficult to assess with conventional immunohisto-
chemistry in patients with clinically staged T3 primary colorectal
carcinoma, without metastatic spread, by using CLE combined
with fluorescently labeled anti-CD31 antibodies for labeling of
both normal and tumor blood vessels.
Materials and Methods
Ethics Statement
This study was conducted in accordance to the Declaration of
Helsinki and approved by the Ethics Committee of the University
of Medicine and Pharmacy of Craiova. A written informed
consent was given to each patient prior to study entry.
Patient Characteristics
The biopsy samples were obtained from five patients recruited
at the Research Center of Gastroenterology and Hepatology
Craiova, Romania before undergoing any therapy (Table S1). The
patients were previously diagnosed with primary colorectal
adenocarcinoma (G1–G2 histologic grade) during routine colo-
noscopy procedures. Patient 1 underwent treatment with borte-
zomib in combination with chemotherapy and radiation followed
by surgery. Patient 2 had a history of surgery followed by
chemotherapy for malignant neoplasm of rectosigmoid junction
four years before and was diagnosed with local recurrence at
follow-up. He was treated with surgery and adjuvant chemother-
apy with 5-fluorouracil (5-FU). Patients 3 and 5 underwent
surgical resection followed by chemotherapy, with neoadjuvant
radiation for the one with rectal carcinoma. Patient 4 had a history
of valvular heart disease, chronic hepatitis C infection and low
platelet count and was initially treated with FUFOL regimen, but
refused further therapy including resection. At the time of this
analysis, all five patients were alive at more than one year after the
first evaluation.
Immunohistochemistry evaluation was performed on surgical
specimens from four patients, while endoscopic biopsies collected
before the initiation of chemotherapy were used for the patient
who refused the operation.
The patients were prepared for colonoscopy by ingesting a
commonly prescribed oral electrolyte lavage solution. Paired
biopsies were collected using a colonoscope (CFQ160ZL, Olym-
pus, Tokyo, Japan) from normal mucosa taken at approximately
10 cm from the tumor and from every macroscopically visible
lesion and immediately immersed in physiological saline. The fresh
biopsy specimens were incubated in the dark with an Alexa-Fluor
488-labeled anti-CD31 (PECAM) antibody (mouse anti-human
IgG1, diluted as 1:10 in PBS with 1% BSA, Exbio, Prague, Czech
Republic) for 1 hour at 37uC. The incubation time and dilution
ratio were optimized to give the highest penetration inside the
tissue and the strongest fluorescence signal for fresh biopsy samples
as described before [9]. Immediately after incubation, the biopsy
samples were placed on glass slides to be imaged with the CLE
method.
Confocal Laser Endomicroscopy
Imaging was performed using a dedicated endomicroscopy
system (Pentax EC-3870 CIFK, Tokyo, Japan), with an excitation
wavelength of 488 nm and with a maximum laser power output of
#1 mW at the surface of the tissue controlled by the user during
the examination for optimal imaging contrast. The CLE
procedure was performed as follows: the distal tip of the endoscope
was placed on the respective mucosal area from the histology glass
slides, followed by collection of serial confocal images (7 mm thick,
0.7 mm lateral resolution and the field of view of
475 mm6475 mm) up to a maximum depth of 250 mm by pressing
a foot switch pedal.
CLE Image Processing and Analysis
The location with the best vascular coverage throughout the
entire depth of the biopsy sample was chosen for the morpho-
metric measurements. For each patient, 80–100 serial images for
each biopsy sample, tumor vs. normal tissue were combined into
image stacks. The Z projection of each image stack was obtained
using the ImageJ NIH software (National Institutes of Health,
Bethesda, Maryland, SUA) to analyze the entire vascular network
captured in the biopsy sample (Fig. 1 A and B). All images were
calibrated and a color overlay was used for a better distinction of
the vasculature. To account for spatial heterogeneity within each
sample, two 506475 mm rectangular regions of interest (ROIs)
centered in the middle of each image in the horizontal and vertical
direction were marked on the image (Figure 1 C and D). The
50 mm width of the ROI was chosen upon inspection of all
samples to allow several bifurcations and entire vessel segments in
each sample. The morphometric parameters were measured in
each ROI and then averaged to obtain a single value for each
sample.
Vascular Parameter Measurements
The vessel diameters, vessel density, vessel length, tortuosity
index and daughter/mother ratio were measured for each vessel in
the ROI. The values for the two ROI per patient were averaged to
obtain an average value per patient. Finally, the values for each
patient were averaged over all patients and the results expressed as
the mean 6 standard error (Table 1). The vessel density was
calculated as the mean number of vessels per ROI divided by the
scanned volume (ROI area multiplied by a depth of 250 mm in the
Z direction) and then normalized to a 1 mm
3 volume.
Using the ImageJ’s straight line function, the diameter of each
vascular segment which fell entirely or partially in the ROI was
measured between two adjacent branching points.
Targeted CLE Morphometry in Colorectal Cancer
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samples was measured by tracing the center line of each vessel
segment using the segmented line tool. The tortuosity index of
each vessel segment was calculated as the ratio of segmented and
straight line lengths. The daughter/mother ratio (DMR) was
computed as the ratio of the sum of the squares of daughter vessel
radii over the square of the mother vessel radius, considering the
mother as the largest vessel at a branching point. This
measurement is an indication of the departure from a tree
structure topology in which case the DMR is roughly one.
Histopathological Assessment
The histopathological assessment was performed on surgical
specimens (rather than the fresh biopsy samples used for CLE),
with one exception when an endoscopic biopsy was used from a
patient who refused surgical intervention. The specimens were
fixed in 4% neutral buffered formalin and processed for routine
Figure 1. Ex-vivo CLE Vascular measurements of Vessel Length and Tortuosity Index. The Z projection of the image stack for normal (A)
and tumor (B) microvasculature, apparently with more tortuous branched vessels. The vessel length was measured using segmented line tool and
reported in micrometres. The tortuosity index was calculated as the ratio of segmented and straight line lengths for both normal (C) and malignant
(D) human colorectal tissue. *The scale bar is 50 mm.
doi:10.1371/journal.pone.0091084.g001
Table 1. Average values of the morphometric parameters measured with CLE.
Morphometric Parameters Normal Mucosa Colorectal Tumor P Value
Vessel Diameter (mm) 7.6060.3 9.4660.4 0.0166
Vessel Density (vessels/mm
3) 3755.796194.96 5541.056262.81 0.0006
Vessel Length (mm) 28.3063.27 26.4963.18 0.7033
Tortuosity Index 1.0560.01 1.0760.01 0.5357
Daughter/Mother Ratio 1.1560.09 1.2160.08 0.6531
The values are expressed as the mean 6 standard error.
doi:10.1371/journal.pone.0091084.t001
Targeted CLE Morphometry in Colorectal Cancer
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(Supporting Information S1).
From each block, a slide was stained with hematoxylin- eosin for
pathological diagnosis, and the next serial sections were utilized for
immunohistochemistry to visualize the CD31 antigen. Briefly,
after microwaving in citrate buffer (pH=6), as an antigen retrieval
method, the sections were cooled to room temperature and
incubated for 30 minutes in 1% hydrogen peroxide in order to
quench endogenous peroxidase. In order to block the unspecific
antigenic sites, the specimens were blocked for 30 minutes in 2%
skim milk (Bio-rad, Mu ¨nchen, Germany) and the first antibody
was incubated over-night at 4uC (anti-CD31, mouse anti-human,
IgG1, clone JC70A, Dako, Glostrup, Denmark, diluted as 1:100 in
PBS with 1% BSA). The next day, the slides were washed, the
signal from the first antibody was amplified using a peroxidase-
conjugated polymeric system (EnVision Dako, Redox, Bucharest,
Romania), and then detected with 3,39-diaminobenzidine – DAB
(Dako). All washing steps were done in 1x PBS buffer. After a
hematoxylin staining, the slides were coversliped and evaluated
using a Nikon Eclipse 55i microscope (Nikon, Tokyo, Japan)
coupled to a 5 Mp color CCD camera (Nikon) and an image-
analysis station (Image ProPlus AMS software, Media Cybernetics,
Bethesda, Maryland, USA).
Four images from the highest vascular density areas were
captured under the same illumination conditions and with a 40x
objective for each case, and archived as uncompressed TIFF
images. A stylus-design pen was utilized to draw the outlines of the
vessels (as visualized by the DAB staining) in the Image ProPlus
software package. All these regions of interest (ROIs) were pseudo-
colored in black and measured automatically as total vascular
areas and total vascular numbers per 40x area, after which the
results were normalized for 1 mm
2 areas. All final measurements
utilized the mean values for all the images captured from each case
and histopathological profile.
Statistical Analysis
The morphometric measurements obtained in ImageJ were
exported for data analysis in Microsoft Office Excel (Microsoft,
Redmond, Washington, USA). Results were expressed as the
mean 6 standard error. All measured vessel parameters were
considered to be derived from a normal distribution as before [9],
[10], and therefore statistical differences between normal and
tumor vasculature were calculated using the Student’s t-test, and
p-values #0.05 were considered to be statistically significant.
Results
Confocal Laser Endomicroscopy
The CLE procedure gave a detailed observation of adjacent
tumor and normal mucosa sections with visible fluorescent signal
(Fig. 1). Both the normal and tumor vessels seem tortuous overall
but it was not clear from the visual analysis of the images whether
there is a significant difference between normal and tumor vessels
or whether the tortuosity is maintained at the level of individual
vascular fragments.
The mean diameter of vessels in the tumor samples
(9.4660.4 mm) was significantly larger than in the normal sample
(7.6060.3 mm, p=0.0166) (Table 1). Similarly, the vessel density
was significantly higher in the colorectal cancer (5541.056262.81
vessels/mm
3) than the normal colorectal mucosa
(3755.796194.96 vessels/mm
3, p=0.0006).
Contrary to the visual evaluation, the tortuosity index and vessel
length were not statistical different between normal (tortuosity
index was 1.0560.016 and vessel length was 28.3063.27 mm) and
tumor tissue (tortuosity index was 1.0760.008 and vessel length
26.4963.18 mm) (Table 1). The mean daughter/mother ratio was
1.1560.09 in the normal sample and 1.2160.08 in the tumor
samples (p=0.6531). The data for each patient are presented in
Table 2. Although a small sample size, there are no large
variations between patients. As a possible exception, in patient 2
the values for the daughter/mother ratios were larger than 1 in
both the tumor and normal samples and (1.53 and 1.46
respectively) which might reflect a particularly vascularized and
heterogeneous vasculature but on average over all patients, the
values were close to 1.
Immunohistochemistry
In order to see whether the CLE vessel signals were correlated
with histological data, the vessel diameter and the vessel density
detected by CLE were qualitatively compared to the CD31-
stained vessels in a histological section from the same patient. The
vascular area was 8.1961.35% in colorectal cancer, significantly
higher than in normal mucosa, 3.1760.48% (p=0.0084). The




2 respectively, p=0.0280, Table 3).
Discussions and Conclusions
Typically, in tumor vascular studies the microvasculature is
described only from the vessel diameter and density points of view
because these features can be measured from histological slices.
We have also performed an immunohistochemical study on our
samples, and obtained similar results to the literature (larger MVD
and vascular area in tumors vs. normal tissue) [9], [11], [12], [13].
In addition, we evaluated more parameters of vascularization from
volumetric samples, such as the vessel length, the index of
tortuosity and the daughter/mother ratio, that can be easily
quantified with CLE due to its greater penetration depth into the
tissue (up to 250 mm). To our knowledge, this is the first report of
the daughter/mother ratios and tortuosity index in colorectal
cancer vasculature.
Anatomically, tumor microvessels are generally more dilated,
tortuous, and saccular with irregular patterns of interconnection
and branching [14]. The overexpression of some pro-angiogenic
factors, like VEGF, leads to formation of a new vasculature that is
structurally abnormal at macroscopic and microscopic levels and it
is generally considered that these abnormalities are exacerbated as
the tumor continues to develop [15]. Consequently, the micro-
vessel density increases gradually from low-grade to high-grade
neoplasia to cancer [16]. Similarly in the present study we have
found a significantly higher vessel density and diameter of tumor
vessels.
Most of the literature gives only a qualitative analysis on the
vessel length and tortuosity in colorectal cancer. Yuan et al. (1996)
provided early evidence that neutralization of tumor-cell-derived
VEGF could reverse some of the abnormalities of the tumor
microvasculature like vascular diameter and tortuosity [17].
Taking into consideration the fact that one strategy for successful
treatment with anti-angiogenic agents is to reduce the tortuosity of
the abnormal vessels [18], a quantitative assessment is necessary.
Generally, vascular tortuosity was evaluated from 2D images [19].
Previous research defined different types of vessel tortuosity
depending on vessel length and showed that vessel tortuosity and
length are variable in tumors [20]. In our confocal optical sections,
the malignant blood vessels appeared more dilated and more
tortuous compared to the normal samples. Interestingly, in spite of
the visual examination, we obtained no statistical significance
Targeted CLE Morphometry in Colorectal Cancer
PLOS ONE | www.plosone.org 4 March 2014 | Volume 9 | Issue 3 | e91084when we calculated their index of tortuosity. This could reflect the
fact that the tortuous appearance might be given by the
mechanical deformation as the entire tumor tissue grows rather
individual vessel fragments being tortuous. One recent three-
dimensional quantification study showed no differences regarding
tortuosity and vessel length between capillaries in healthy and
cancerous tissues [21], while quantitative studies in three-
dimensional tumors at later stages of growth showed a decrease
in vessel length [20], [22], [23].
There was not a significant difference in the daughter/mother
ratio between normal and tumor branching network and the
values are close to 1 (1.1560.09 vs. 1.2160.08). This parameter is
derived from Murray’s law for connecting large vessels to small
vessels applied in colorectal cancer angiogenesis. Murray’s law,
available for asymmetrical as well as symmetrical branching
systems, states that the cube of the radius of a parent vessel equals
the sum of the cubes of the radii of the daughters and refers to the
optimization of blood vessel diameter and of blood volume
according to the metabolic requirements [24]. One limitation of
our study is that the direction of blood flow is not known, therefore
the exact designation of the mother vessel cannot be specified.
This shortcoming could be addressed with the in vivo observation
of blood flow in tumors, using clinically approved contrast agents.
The utility of using morphometric parameters as biomarkers
could depend on the stage of tumor development. We calculated
the morphometric parameters which measure different aspects of
colorectal tumor microvasculature taking into consideration only
T3 staged, well to moderately differentiated carcinoma (G1–G2
grade), without metastasis. In 1997, Robert D. Cardiff et al.
calculated the index of tortuosity in a study based on a mouse
mammary tumor model system, using histology combined with
computer-assisted intravital microscopy and mice injected with
FITC [25]. He considered this parameter a prognostic factor and
demonstrated that it was statistically significant when correlated
with a higher metastatic rate. Similarly, further long-term studies
on larger groups of patients are necessary to see if all
morphometric parameters show strong association with colorectal
adenocarcinoma grading and if they might correlate with
treatment outcome and prognosis.
Other methodology could be applied to studies which monitor
the effect of anti-angiogenesis therapy (e.g. bevacizumab) on
vascular branching, tortuosity and vessel volume in tumors [8],
[26].
As the efficacy of chemotherapy depends on the presence of an
adequate tumor blood supply to ensure drug delivery, ‘‘normal-
ization’’ of the tumor vascular network is desirable. Thus, assessing
the differences between the vessel length, tortuosity and branching
patterns with CLE imaging and fresh biopsy staining could be
useful for identifying the cathegory of patients who might benefit
from neoadjuvant angiogenetic therapy. [27].
Currently, three-dimensional confocal laser endomicroscopy
reconstruction represents a challenge [28–30]. Using CD 31
antibodies fluorescently labeled with a fluorochrome (Alexa Fluor
488) and CLE for identification of vessels from fresh biopsy
samples, we could estimate their shape, branching features and
density. Two major advantages of this method are the shorter
processing time (an hour vs. several hours to days), and no artifacts
from tissue fixation and processing for IHC. Future similar studies
could include more specific markers for tumour neoangiogenesis as
compared to the panendothelial marker used in the current study.
A direct comparison of the morphometric parameters between
CLE and IHC is difficult and of limited relevance. One would
have to compare the results from one paraffin-embedded tissue
section used in conventional IHC for clinical diagnosis, with the
information from the 3D stack obtained in a single CLE scan that
was analyzed in the present study. A 2D slice does not allow an
accurate measurement of the vessel length, tortuosity or mother/
daughter ratios. Another difficulty is that the CD31 antibody and
the tissue processing steps (fresh versus fixed and paraffin-
embedded) are different between the two staining techniques,
and are likely to generate different values for the same parameter
due to differences in processing techniques.
Table 2. Vascular parameters of individual patients measured with the CLE method.
Confocal Laser Endomicroscopy
Patient Control Tumor
DMR VL TI DMR VL TI
1 1.22 36.27 1.03 1.14 26.67 1.06
2 1.46 25.18 1.06 1.53 25.70 1.07
3 1.17 21.48 1.12 1.07 15.24 1.10
4 0.86 22.48 1.05 1.20 30.81 1.07
5 1.05 36.10 1.03 1.12 34.07 1.05
DMR- daughter/mother ratio, VL- vessel length, TI- tortuosity index.
doi:10.1371/journal.pone.0091084.t002
Table 3. Average vascular parameters measured from Anti-CD31 Immunohistochemistry samples.
Vascular Parameters Normal Mucosa Colorectal Tumor P Value
Vascular Area (%) 3.1760.48% 8.1961.35% 0.0084
MVD (vessels/mm
2) 185.73633.21 309.28632.26 0.0280
The values are expressed as the mean 6 standard error.
doi:10.1371/journal.pone.0091084.t003
Targeted CLE Morphometry in Colorectal Cancer
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the confocal laser endomicroscopy is feasible for measuring more
vascular parameters from fresh tumor biopsies than conventional
immunohistochemistry alone. Moreover, we have presented a
framework that captures some of the essential features of colorectal
cancer microvascularization, using a reproducible non-invasive
technique and targeted panendothelial markers on fresh biopsies.
Verification should be done in future experiments using confocal
laser endomicroscopy in vivo by manipulating tumor morphology
through variations in tumor vascularization. Provided new
contrast agents will be clinically available, future in vivo use of
CLE could lead to identification of novel biomarkers based on the
morphometric characteristics of tumor vasculature.
The results are useful for further understanding of the colorectal
cancer development and patient selection criteria. Furthermore, as
defined by Ehling J et al (2013), non-invasive characterisation of
tumour vessels leads to a better understanding of therapy effects,
helps optimize and personalize therapeutic interventions [8]. The
results extend our previous feasibility findings to the evaluation of
new vascular parameters, which are important in the management
of cancer, but which are difficult to measure from immunohisto-
chemical sections (the vessels/mm
3, the vessel length, the index of
tortuosity and the mother/daughter ratio). We have shown the
reproducibility of the method by comparing the two common used
parameters (vessel diameter, vessel density) to the traditional
immunohistochemistry. Using CLE imaging technique for ana-
lyzing the 3D microvascular architecture of tumors is suitable for
both quantitative and qualitative angiogenesis measurements
in vivo and combined with targeted antibodies.
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